Document ID: FDA-2013-N-0365-0008
Agency: fda
Document Type: Rule
Title: Administrative Detention of Drugs Intended for Human or Animal Use;
Correction
Posted Date: 2015-04-22T04:00Z

[Federal Register Volume 80, Number 77 (Wednesday, April 22, 2015)]
[Rules and Regulations]
[Page 22403]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-09301]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Parts 1 and 16

[Docket No. FDA-2013-N-0365]

Administrative Detention of Drugs Intended for Human or Animal 
Use; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a final 
rule entitled ``Administrative Detention of Drugs Intended for Human or 
Animal Use'' that appeared in the Federal Register of May 29, 2014 (79 
FR 30716). The rule sets forth the procedures for detention of drugs 
believed to be adulterated or misbranded and amends the scope of FDA's 
part 16 regulatory hearing procedures to include the administrative 
detention of drugs. The rule published with incorrect statements 
regarding the impact of the final rule on small entities. This document 
corrects those errors.

DATES: Effective April 22, 2015 and applicable beginning June 30, 2014.

FOR FURTHER INFORMATION CONTACT: Emily Leongini, Office of Regulatory 
Affairs, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 
32, Rm. 4339, Silver Spring, MD 20993-0002, 301-796-5300, 
FDASIAImplementationORA@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: In the Federal Register of May 29, 2014, in 
FR Doc. 2014-12458, the following corrections are made:
    1. On page 30718, in the third column, under ``Analysis of Impacts 
(Summary of the Regulatory Impact Analysis),'' the last sentence of the 
second paragraph is corrected to read: ``FDA certifies that this final 
rule will not have a significant economic impact on a substantial 
number of small entities.''
    2. On page 30719, in the first column, the third sentence of the 
last full paragraph is corrected to read: ``We certify that this final 
rule will not have a significant economic impact on a substantial 
number of small entities.''

    Dated: April 16, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-09301 Filed 4-21-15; 8:45 am]
BILLING CODE 4164-01-P